PIM
CBPO

Paradice Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Paradice Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,168
Closed -$2.42M – 48
2019
Q3 		$2.42M Buy
21,168
+17,258
+441% +$1.72M 0.18% 39
2019
Q2 		$373K Buy
+3,910
New +$368K 0.03% 43

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paradice Investment Management's CBPO Position: Q4 2019 in Review

Paradice Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2019, closing a stake of 21,168 shares — an estimated $2.42M sold.

Paradice Investment Management first reported a position in CBPO in Q2 2019 and held it in 2 quarters. The position peaked at $2.42M in Q3 2019. 87 funds tracked by Wall St. Rank hold CBPO as of Q4 2019.

  • Paradice Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2019 after selling out during the quarter.
  • Paradice Investment Management sold 21,168 China Biologic Products Holdings, Inc. shares in Q4 2019, an estimated $2.42M.
  • Paradice Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2019 and held it in 2 quarters.
  • Paradice Investment Management's China Biologic Products Holdings, Inc. position peaked at $2.42M in Q3 2019.
  • 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2019.

Based on Paradice Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.